NCCN Guidelines Version 1.2023
- Ductal Carcinoma in situ (DCIS)
- Invasive Breast Cancer
- Special consideration: Breast Cancer During Pregnancy
- Special consideration: Inflammatory Breast Cancer
- Special consideration: Paget Disease
- Special consideration: Phyllodes Tumor
Basic Resources (English) Version 3.2020 (Preliminary)
Core Resources (English) Version 3.2020 (Preliminary)
Enhanced Resources (English) Version 3.2020 (Preliminary)
Invasive Breast Cancer-English Version 2022
Metastatic Breast Cancer-English Version 2022
DCIS Breast Cancer-English Version 2022
DCIS Breast Cancer-Spanish - Latin America Version 2022
Metastatic Breast Cancer-Spanish - Latin America Version 2022
Invasive Breast Cancer-Spanish - Latin America Version 2022
Metastatic Breast Cancer-Ukrainian Version 2020
DCIS Breast Cancer-Ukrainian Version 2020
Invasive Breast Cancer-Ukrainian Version 2020
Continuing Education
Genetic/Familial Risk Assessment for Breast Cancer: Testing Considerations and Controversies
Surgical Management of Non-Metastatic Breast Cancer with SABCS Updates
Radiation Therapy for Non-Metastatic Breast Cancer with SABCS Updates
Neoadjuvant and Adjuvant Treatment for Breast Cancer with SABCS Updates
Locoregional Management of Patients with Early-Stage Breast Cancer
NCCN Guidelines® Updates: Management of Patients with HER2-Negative Breast Cancer
Targeted Therapy for Patients with Metastatic Non-Small Cell Lung Cancer
Monthly Oncology Tumor Boards: Management of Early Stage Breast Cancer
Archived Monthly Oncology Tumor Boards: Management of Early Stage Breast Cancer
Translations
Chinese Version 4.2022
French Version 8.2021
Italian Version 2.2022
Japanese Version 5.2020
Korean Version 6.2020
Polish Version 6.2020
Portuguese Version 6.2020
Spanish Version 2.2022
Ukrainian Version 2.2022
Adaptations
English (Middle East & North Africa) Version 2.2016
Spanish (European/Spain) Version 3.2019
Harmonized
English (Caribbean) Version 1.2018
English (Africa) Version 4.2021